GRI Bio, Inc. (GRI)
1.80
-0.03
(-1.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:31
GRI Bio Max Drawdown (5Y) : 100.0% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 100.0% |
| September 30, 2026 | 100.0% |
| August 31, 2026 | 100.0% |
| July 31, 2026 | 100.0% |
| June 30, 2026 | 100.0% |
| May 31, 2026 | 100.0% |
| April 30, 2026 | 100.0% |
| March 31, 2026 | 100.0% |
| February 28, 2026 | 100.0% |
| January 31, 2026 | 100.0% |
| December 31, 2025 | 100.00% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 100.00% |
| August 31, 2025 | 100.00% |
| July 31, 2025 | 100.00% |
| June 30, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| April 30, 2025 | 100.00% |
| March 31, 2025 | 100.00% |
| February 28, 2025 | 100.00% |
| January 31, 2025 | 100.00% |
| December 31, 2024 | 100.00% |
| November 30, 2024 | 100.00% |
| October 31, 2024 | 100.00% |
| Date | Value |
|---|---|
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 99.99% |
| May 31, 2024 | 99.99% |
| April 30, 2024 | 99.98% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.92% |
| December 31, 2023 | 99.89% |
| November 30, 2023 | 99.82% |
| October 31, 2023 | 99.63% |
| September 30, 2023 | 99.60% |
| August 31, 2023 | 99.58% |
| July 31, 2023 | 98.80% |
| June 30, 2023 | 98.54% |
| May 31, 2023 | 98.08% |
| April 30, 2023 | 97.95% |
| March 31, 2023 | 97.78% |
| February 28, 2023 | 97.78% |
| January 31, 2023 | 97.78% |
| December 31, 2022 | 97.78% |
| November 30, 2022 | 97.60% |
| October 31, 2022 | 97.38% |
| September 30, 2022 | 97.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 66.41% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 93.79% |
| Vericel Corp. | 73.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -89.83 |
| Beta (5Y) | -1.127 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 136.3% |
| Historical Sharpe Ratio (5Y) | -0.7268 |
| Historical Sortino (5Y) | -1.312 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 71.76% |